tiprankstipranks
Zelira Therapeutics (AU:ZLD)
ASX:ZLD

Zelira Therapeutics (ZLD) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
1Neutral
7Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
5Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Zelira Therapeutics’s (ZLD) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting Zelira Therapeutics is a Sell.
Zelira Therapeutics’s (ZLD) 20-Day exponential moving average is 0.45, while Zelira Therapeutics’s (ZLD) share price is AU$0.99, making it a Buy.
Zelira Therapeutics’s (ZLD) 50-Day exponential moving average is 0.49, while Zelira Therapeutics’s (ZLD) share price is AU$0.99, making it a Buy.

Zelira Therapeutics (ZLD) Pivot Points

Jul 22, 2024, 04:12 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.42
0.46
0.53
0.57
0.64
0.68
0.75
Fibonacci
0.46
0.50
0.53
0.57
0.61
0.64
0.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zelira Therapeutics (ZLD) Moving Averages

Jul 22, 2024, 04:12 PM
Period
Simple
Exponential
MA5
0.53Buy
0.58Buy
MA10
0.45Buy
0.50Buy
MA20
0.40Buy
0.45Buy
MA50
0.47Buy
0.49Buy
MA100
0.61Buy
0.59Buy
MA200
0.77Sell
0.78Sell
Zelira Therapeutics’s (ZLD) 10-Day exponential moving average is 0.50, while Zelira Therapeutics’s (ZLD) share price is AU$0.99, making it a Buy.
Zelira Therapeutics’s (ZLD) 100-Day exponential moving average is 0.59, while Zelira Therapeutics’s (ZLD) share price is AU$0.99, making it a Buy.
Zelira Therapeutics’s (ZLD) stock price is AU$0.99 and Zelira Therapeutics’s (ZLD) 50-day simple moving average is 0.47, creating a Buy signal.
Zelira Therapeutics’s (ZLD) stock price is AU$0.99 and Zelira Therapeutics’s (ZLD) 100-day simple moving average is 0.61, creating a Buy signal.
Zelira Therapeutics’s (ZLD) stock price is AU$0.99 and Zelira Therapeutics’s (ZLD) 200-day simple moving average is 0.77, creating a Sell signal.

Zelira Therapeutics (ZLD) Technical Indicators

Jul 22, 2024, 04:12 PM
Name
Value
Implied Action
RSI (14)
76.83
Sell
STOCH (9,6)
99.49
Sell
STOCHRSI (14)
99.49
Sell
MACD (12,26)
0.03
Sell
ADX (14)
33.77
Neutral
Williams %R
0.00
-
CCI (14)
307.04
Sell
ATR (14)
0.05
-
Ultimate Oscillator
79.45
Buy
ROC
104.05
Buy
Zelira Therapeutics’s (ZLD) Relative Strength Index (RSI) is 76.83, creating a Sell signal.
Zelira Therapeutics’s (ZLD) Trend Strength Indicator (ADX) is 33.77, creating a Neutral signal.
Zelira Therapeutics’s (ZLD) Commodity Channel Index (CCI) is 307.04, creating a Sell signal.
Zelira Therapeutics’s (ZLD) Price Rate of Change (ROC) is 104.05, creating a Buy signal.

FAQ

Is ZLD a Buy, Hold, or Sell?
Based on ZLD’s technical indicators, ZLD is a Buy.
    What is ZLD’s RSI (14)?
    ZLD’s RSI (14) is 76.83, which suggests ZLD is a Sell.
      What is ZLD’s MACD?
      ZLD’s MACD is 0.03, which suggests ZLD is a Sell.
        What is ZLD’s 5-day moving average?
        ZLD’s 5-day moving average is 0.53, which suggests ZLD is a Buy.
          What is ZLD’s 20-day moving average?
          ZLD 20-day moving average is 0.40, which suggests ZLD is a Buy.
            What is ZLD’s 50-day moving average?
            ZLD’s 50-day moving average is 0.47, which suggests ZLD is a Buy.
              What is ZLD’s 200-day moving average?
              ZLD’s 200-day moving average is 0.77, which suggests ZLD is a Sell.
                What is ZLD’s Williams % R (14)?
                Currently, no data Available
                What is ZLD’s CCI (14)?
                ZLD’s CCI (14) is 307.04, which suggests ZLD is a Sell.
                  What is the share price of Zelira Therapeutics?
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis